Tag: Novartis
Novartis revises upwards its forecasts for 2024
Published on 04/23/2024 at 7:57 a.m. FRANKFURT, April 23 (Reuters) – Swiss drugmaker Novartis raised its full-year forecast on Tuesday after beating…
Novartis revises upwards its forecasts for 2024
Published on 04/23/2024 at 08:41 a.m. Photo credit © Reuters FRANKFURT (Reuters) – Swiss drugmaker Novartis…
Novartis: Oddo BHF confirms its advice on the stock
(CercleFinance.com) – Oddo BHF maintains its ‘neutral’ rating on Novartis shares, with an unchanged price target of 95 Swiss francs. The analysis office recalls that Q1 came out above expectations…
Change in leadership position: Novartis unexpectedly raises forecast
Change in the leadership position Novartis unexpectedly raises forecast April 23, 2024, 3:36 p.m The heavily restructured pharmaceutical company Novartis reports solid growth in the first quarter of the year.…
Basel pharmaceutical company – Novartis increases profits in the first quarter – News
Basel pharmaceutical company – Novartis increases profits in the first quarter – News – SRF Skip to content Some elements on SRF.ch only work with JavaScript activated. News Business Current…
Novartis: Positive efficacy data in MS
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Novartis: UBS reiterates its advice on the stock
(CercleFinance.com) – UBS estimates that the adjustments to Kisqali production have a limited impact. The analyst confirms his purchase advice on the stock with a price target of 104 E…
Novartis: changes in the production system
(CercleFinance.com) – Novartis announced Tuesday evening that it had implemented a series of measures intended to meet new regulatory standards surrounding early-stage breast cancer treatments. The biopharmaceutical group indicates that…
Market: Novartis to cut 680 product development jobs
ZURICH (Reuters) – Novartis will cut up to 680 jobs in the development sector, which helps bring its drugs to market, the Swiss pharmaceutical group said on Tuesday. Around 440…
Novartis: Positive opinion from the CHMP to market Fabhalta
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Novartis: New positive data for Zolgensma
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Novartis in advanced talks to acquire MorphoSys
Published on 02/05/2024 at 6:01 p.m. Feb 5 (Reuters) – Drugmaker Novartis is in advanced talks to acquire German group MorphoSys AG, a…